Mahshid Assadi is a Cardiology physician affiliated with State University of New York. OpenAlex indexes 9 publications with 256 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
25 Central Park West
Suite 1m Mahshid Arfania Assadi Md Pc
Nyc, NY 10023
Telephone
212-315-3322Registry record last updated 22 Dec 2011.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year202513 payments
- AstraZeneca Pharmaceuticals LPProgram year202519 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
40.6%Statin10.6%Rosuvastatin Calcium58%Atorvastatin Calcium30%Simvastatin12%Part D≥82 patientsAngiotensin receptor blocker (ARB)6.2%Losartan Potassium54%Olmesartan Medoxomil33%Olmesartan-Hydrochlorothiazide7%Losartan-Hydrochlorothiazide6%Part D<11 patients+ 13 more classes in this area
Metabolism & gastrointestinal
31.2%SGLT2 inhibitor7.7%Farxiga67%Jardiance29%Dapagliflozin4%Part D<11 patientsProton pump inhibitor3.8%Omeprazole73%Pantoprazole Sodium18%Esomeprazole Magnesium9%Part D<11 patients+ 16 more classes in this area
Nervous system
11.6%Opioid Agonist3.9%Oxycodone Hcl40%Oxycodone-Acetaminophen32%Tramadol Hcl29%Part D<11 patientsBenzodiazepine1.5%Clonazepam36%Diazepam32%Lorazepam32%Part D<11 patients+ 12 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Efficacy of Azimilide and Dofetilide in the Dog Right Atrial Enlargement Model of Atrial Flutter
Journal of Cardiovascular Electrophysiology
2001 - Actions of lidocaine on reentrant ventricular rhythms in the subacute myocardial infarction period in dogs
American Journal of Physiology-Heart and Circulatory Physiology
1997 - Effects of Azimilide Dihydrochloride on Circus Movement Atrial Flutter in the Canine Sterile Pericarditis Model
Journal of Cardiovascular Electrophysiology
1996
Similar KOLs
Other experts from the same institution or the same specialty.
Harold Lebovitz, MD
State University of New York
Samy McFarlane, MD
State University of New York
Joseph Franciosa, MD
State University of New York
Sheldon Landesman, MD
State University of New York
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”